Late recurrence in patients with non‐muscle‐invasive bladder cancer after 5‐year cancer‐free periods-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Late recurrence in patients with non‐muscle‐invasive bladder cancer after 5‐year cancer‐free periods

Published:2022-05-21 Issue:10 Volume:29 Page:1140-1146
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int J of Urology

Author:

Hirata Yurie¹^ORCID,Higuchi Madoka¹,Osawa Takahiro¹,Hinotsu Shiro²,Harabayashi Toru³,Mochizuki Tango⁴,Enami Nobuyasu⁵,Nounaka Osamu⁶,Shinno Yuichiro⁷,Kikuchi Hiroshi¹^ORCID,Matsumoto Ryuji¹,Abe Takashige¹^ORCID,Murai Sachiyo¹,Shinohara Nobuo¹

Affiliation:

1. Department of Renal and Genitourinary Surgery, Graduate School of Medicine Hokkaido University Sapporo Japan

2. Department of Biostatistics Sapporo Medical University Sapporo Japan

3. Department of Urology Hokkaido Cancer Center Sapporo Japan

4. Department of Urology Asahikawa City Hospital Asahikawa Japan

5. Department of Urology Nikko Memorial Hospital Muroran Japan

6. Department of Urology Chitose City Hospital Chitose Japan

7. Department of Urology Otaru General Hospital Otaru Japan

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/iju.14936

Reference17 articles.

1. Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials

2. Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline

3. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update

4. Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

5. Late Recurrence and Progression in Non-muscle–invasive Bladder Cancers After 5-year Tumor-free Periods

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial Comment to Late recurrence in patients with non‐muscle‐invasive bladder cancer after 5‐year cancer‐free periods;International Journal of Urology;2022-06-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3